Clinical Trials Insight: 700029392

Trial Profile

Clinical Trials Insight: 700029392

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2008

At a glance

  • Drugs Laninamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Biota Holdings
  • Most Recent Events

    • 31 Jul 2008 Biota Holdings reported that dosing of CS 8958 was completed.
    • 31 Jul 2008 Status changed from unconfirmed to in progress, based on a Biota Holdings media release.
    • 20 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top